The U.S. Food and Drug Administration (FDA) on July 14 approved Veklury, also known as remdesivir, to treat COVID-19 in people with severe renal impairment, including dialysis, despite data showing the drug increases the risk of kidney failure. Remdesivir is an antiviral medication that targets the RNA in viruses to prevent replication. The FDA first…